MYD88 and metabolic dysfunction-associated steatohepatitis: B-cell deficiency ameliorates the progression of NASH through MyD88 signaling. FMT from NAFLD patients promotes the pathogenesis of NASH mice by increasing the activation and accumulation of intrahepatic B cells [251].